Related Experiment Video

Updated: Oct 27, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.2K

Metabolic landscapes in sarcomas

Richard Miallot1, Franck Galland2, Virginie Millet2

  • 1Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Centre d'Immunologie de Marseille Luminy, Aix Marseille Univ, Marseille, France. miallot@ciml.univ-mrs.fr.

Journal of Hematology & Oncology
|July 23, 2021
PubMed

Insights

Metabolic rewiring in cancer offers new therapeutic avenues. This review details how genetic changes drive metabolic shifts in soft tissue sarcomas, impacting the tumor microenvironment and treatment strategies.

Area of Science:

  • Oncology
  • Metabolic pathways
  • Cancer research

Background:

  • Soft tissue sarcomas are notoriously complex due to diverse origins and genetics.
  • Limited understanding of their metabolic landscape has hindered therapeutic development.
  • Recent advances in genomics and metabolomics are improving sarcoma classification.

Purpose of the Study:

  • To review the role of metabolic rewiring in sarcoma development and progression.
  • To highlight novel mechanisms of metabolic regulation in sarcomas.
  • To discuss the impact of metabolic alterations on the tumor microenvironment and patient prognosis.

Main Methods:

  • Comprehensive literature review of genetic alterations, metabolic pathways, and therapeutic strategies in sarcomas.
  • Analysis of large-scale genomic and metabolomics data.
  • Integration of findings related to tumor microenvironment and immune response.

Main Results:

  • Genetic alterations significantly influence metabolic pathways in sarcomas.
  • Newly identified metabolic regulation mechanisms are crucial for sarcomagenesis.
  • Metabolic landscapes dictate the tumor microenvironment, immune surveillance, and patient outcomes.
  • Metabolite-targeting drugs show promise in controlling sarcoma growth.

Conclusions:

  • Metabolic rewiring is a critical factor in sarcoma pathogenesis and progression.
  • Understanding sarcoma-specific metabolic vulnerabilities is key for developing targeted therapies.
  • Targeting metabolic pathways represents a promising therapeutic strategy for soft tissue sarcomas.
Keywords:
MetabolismMetabolite-targeted therapiesMetabolomicsMicroenvironmentSarcomaTranscriptomics

More Related Videos

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.3K
Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening06:50

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening

Published on: September 5, 2025

108

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K